Wholesale of pharmaceutical and medical goods
LOVISENBERG UTVIKLING 3 AS
Revenue 2024
NOK 35.7m
Operating profit
NOK −1.4m
Equity
NOK 6.3m
Incorporated
2012
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 35.7m | |
| Total operating costs | 37.1m | |
| Operating profit (EBIT) | −1.4m | |
| Net financial items | 278k | |
| Profit for the year | −1.3m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 7.1m | |
| of which current assets | 7.0m | |
| Equity | 6.3m | |
| Total liabilities | 776k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.